Systematic Identification of Determinants for Single-Strand Annealing-Mediated Deletion Formation in Saccharomyces cerevisiae

G3 (Bethesda). 2017 Oct 5;7(10):3269-3279. doi: 10.1534/g3.117.300165.

Abstract

To ensure genomic integrity, living organisms have evolved diverse molecular processes for sensing and repairing damaged DNA. If improperly repaired, DNA damage can give rise to different types of mutations, an important class of which are genomic structural variants (SVs). In spite of their importance for phenotypic variation and genome evolution, potential contributors to SV formation in Saccharomyces cerevisiae (budding yeast), a highly tractable model organism, are not fully recognized. Here, we developed and applied a genome-wide assay to identify yeast gene knockout mutants associated with de novo deletion formation, in particular single-strand annealing (SSA)-mediated deletion formation, in a systematic manner. In addition to genes previously linked to genome instability, our approach implicates novel genes involved in chromatin remodeling and meiosis in affecting the rate of SSA-mediated deletion formation in the presence or absence of stress conditions induced by DNA-damaging agents. We closely examined two candidate genes, the chromatin remodeling gene IOC4 and the meiosis-related gene MSH4, which when knocked-out resulted in gene expression alterations affecting genes involved in cell division and chromosome organization, as well as DNA repair and recombination, respectively. Our high-throughput approach facilitates the systematic identification of processes linked to the formation of a major class of genetic variation.

Keywords: Saccharomyces cerevisiae; deletion formation; single-strand annealing; structural variants.

MeSH terms

  • Camptothecin / pharmacology
  • DNA Damage
  • DNA Repair
  • DNA, Fungal / genetics
  • DNA, Single-Stranded
  • DNA-Binding Proteins / genetics*
  • Doxorubicin / pharmacology
  • Gene Expression Profiling
  • Genomic Instability
  • Hydroxyurea / pharmacology
  • Methyl Methanesulfonate / pharmacology
  • Mutagens / pharmacology
  • Mutation
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Saccharomyces cerevisiae / genetics*
  • Saccharomyces cerevisiae Proteins / genetics*
  • Topoisomerase I Inhibitors / pharmacology
  • Topoisomerase II Inhibitors / pharmacology

Substances

  • DNA, Fungal
  • DNA, Single-Stranded
  • DNA-Binding Proteins
  • IOC4 protein, S cerevisiae
  • MSH4 protein, S cerevisiae
  • Mutagens
  • Nucleic Acid Synthesis Inhibitors
  • Saccharomyces cerevisiae Proteins
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors
  • Doxorubicin
  • Methyl Methanesulfonate
  • Hydroxyurea
  • Camptothecin